Havn Life Sciences Inc. (CSE: HAVN) (OTC Pink: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life"), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind today announced that it will be presenting at the upcoming Q3 Investor Summit Virtual Conference. Details of the presentation are below.

WHO: Tim Moore, Havn Life Sciences - CEO
WHEN: Aug 17, 2021 11:00 AM in Eastern Time (US and Canada)
WHERE: To access to the webcast please register at the following link
https://zoom.us/webinar/register/WN_Ggscb7dqSteVALGBH-2V2Q

On Behalf of The Board of Directors
Tim Moore
Chief Executive Officer

About Havn Life Sciences Inc.

HAVN Life Sciences is a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural health products, and innovative mental health treatment to support brain health and enhance the capabilities of the mind. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.

Contact:

Investor Relations: This email address is being protected from spambots. You need JavaScript enabled to view it. 604 687-7130
Media: This email address is being protected from spambots. You need JavaScript enabled to view it. 647 896-8078

Forward-Looking Information 

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future of the Company's business. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. The statements in this news release are made as of the date of this release.